​SafeScript NSW overview

NSW Health has implemented SafeScript NSW, a Real Time Prescription Monitoring (RTPM) system. SafeScript NSW provides prescribers and pharmacists with access to a patient's prescription history for certain high-risk medicines such as opioids and benzodiazepines, which are prone to misuse or can cause dependence. The information in the SafeScript NSW system helps prescribers and pharmacists to make safer clinical decisions for their patients.

What this factsheet will cover

This factsheet is for prescribers and pharmacists who operate close to and across State and Territory (S/T) borders. It explains what patient information is included in SafeScript NSW and the eligibility requirements to register for the system.

Last updated: 30 May 2024
Download

​Is my patient's information included in SafeScript NSW?

Information about a patient's prescribing and dispensing history for monitored medicines will be included in SafeScript NSW as long as their recorded address (as part of the prescribing/dispensing transaction) and/or the clinical transaction takes place in NSW. The table below describes the possible scenarios.

 ​ScenarioInformation included in SafeScript NSW?
​Patient address in NSW​Prescribing and/or dispensing takes place in NSWYes
​Patient address in NSWPrescribing and/or dispensing takes place in another S/T​ Yes
​Patient address in another S/TPrescribing and/or dispensing takes place in NSW​Yes
​Patient address in another S/T​Both prescribing and dispensing take place in another S/TNo

 

Am I able to register for SafeScript NSW if I don't practise in NSW?

All Australian Health Practitioner Regulation Agency (Ahpra) registered practitioners are eligble to register and use SafeScript NSW to view NSW patient prescribing and dispensing of certain high-risk medicines to their patients.

 

Practitioner responsibilities when using SafeScript NSW

Practitioners are permitted to view a patient record in SafeScript NSW in the following circumstances:

  • When prescribing or supplying a monitored medicine to a patient.
  • When reviewing the patient's monitored medicine history as part of a patient consultation.
  • When discussing a patient's monitored medicine history with other registered health practitioners who are involved in that patient's care.

Practitioners are not to view any other patient records for any other reason.

The table below describes the possible scenarios in which a practitioner would use SafeScript NSW.

 

​Scenario Eligible to register and use SafeScript NSW?
​1 ​Practitioner practises in NSW and another S/T Yes
​2 Practitioner does not practise in NSW at all but treats NSW patients​ Yes
​3 Practitioner delivers telehealth to patients located in NSW Yes
​4
Practitioner does not practise in NSW at all but treats a patient who receives treatment from NSW practitioners Yes
5 Practitioner does not practise in NSW or treat any NSW patients No

 

Interstate practitioners who treat NSW patients (Scenarios 2, 3 and 4)

Interstate practitioners are eligible to access SafeScript NSW if they treat a patient who ordinarily resides in NSW or receives treatment from NSW practitioners. This includes when providing telehealth services. When registering for SafeScript NSW, you will be required to read and acknowledge your legal and privacy obligations in the system.

 

Considerations when using SafeScript NSW and other state RTPM systems

Please note that the data collection approaches vary between jurisdictions. Equivalent systems of SafeScript NSW may or may not include interstate records. It is recommended to use the state's jurisdiction's RTPM system in conjunction with SafeScript NSW to ascertain the whole patient's prescribing and dispensing activity. For example, a prescriber who operates near the NSW state border and has NSW and Queensland patients may want to use Queensland's 'QScript' system and NSW's SafeScript NSW system to search for and view their patient's records.

 

Further Information

For enquiries about SafeScript NSW, contact safescript@health.nsw.gov.au

 

Current as at: Thursday 30 May 2024
Contact page owner: Pharmaceutical Services